Advances in diagnostic devices in melanoma screening

Investigating anticarcinogenic compounds as an alternative to chemo

KRAS/NRAS and BRAF mutations in study of panitumumab plus FOLFIRI for second-line treatment of mCC

Ipilimumab and nivolumab achieves long-term survival in advanced melanoma

Comment: HPV-targeted adoptive T cell therapy may provide a new strategy for advanced cervical cancer

Comment: Adjuvant ipilimumab in high-risk melanoma

Comment: Immunotherapy combo increases median survival in advanced melanoma

Success for ipilimumab and nivolumab combo in advanced melanoma

T-VEC injections into melanoma lesions show significant response rate

Addition of docetaxel to initial hormone therapy substantially improves survival in metastatic, hormone-sensitive prostate cancer

Lapatinib not found to be beneficial in head and neck cancer with high risk of recurrence

ASCO 2014 roundup